Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial of the Efficacy and Safety of Dihydroartimisinine+Papiraquine (Artekin) Compared With First Line Drugs for Treatment of Vivax and Uncomplicated Falciparum Malaria in Afghanistan

NCT00682578 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00682578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00682578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial of the Efficacy and Safety of Dihydroartimisinine+Papiraquine (Artekin) Compared With First Line Drugs for Treatment of Vivax and Uncomplicated Falciparum Malaria in Afghanistan
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2007
Completion date
February 28, 2010
Enrollment
1,086 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated falciparum malaria, vivax malaria